Skip to content

Clinical trials

Recruiting Prostatic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Recruiting Country / region: United Kingdom Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20152
20172
20192
20202
20212
20226
20239
202411
202519
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Cancer Research, United Kingdom10
AstraZeneca7
Royal Marsden NHS Foundation Trust4
University College, London4
Janssen Research & Development, LLC3
Astellas Pharma Global Development, Inc.2
East and North Hertfordshire NHS Trust2
Genentech, Inc.2
Imperial College London2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms70
Neoplasms8
Ovarian Neoplasms8
Breast Neoplasms6
Lung Neoplasms6
Pancreatic Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Urinary Bladder Neoplasms5
Head and Neck Neoplasms4
Neoplasm Metastasis4

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.